Vancouver, Canada – June 20, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that the Co-Founders of its wholly-owned subsidiary, Inka Health Corp. ("Inka Health"), have authored a significant new study titled Global Transportability of Clinical Trial Outcomes to Real-World Lung Cancer Populations: A Case Study using Lung-MAP S1400I[i] (the “Study”), published in medRxiv in June 2025. The Study examines a key challenge in global cancer research by exploring how clinical trial results can be made more applicable to ...
[ more ]
